Intrinsic Value of S&P & Nasdaq Contact Us

IRIDEX Corporation IRIX NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+188.5%

Stock Statistics — IRIX

IRIDEX Corporation (IRIX) has a market capitalization of $18M and trades at $1.04. The 52-week range is 0.79-1.65.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4, Earnings Per Share (EPS) of $-0.26, annual revenue of $52.68M.

The stock has a beta of 0.76, operates in the Healthcare sector.

Trading Data
Current Price$1.04
52-Week Range0.79-1.65
Volume63.47K
Avg Volume (30D)275.35K
Market Cap$18M
Beta (1Y)0.76
Company
IPO Date1996-02-16
Employees93
CEOPatrick Mercer
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS4626841013
CUSIP462684101
Income (Latest Year)
Revenue$52.68M
Gross Profit$19.31M
EBITDA$-1.02M
Operating Income$-2.57M
Net Income$-4.44M
EPS$-0.26
EPS Diluted$-0.26
Shares Outstanding$17.19M
Balance Sheet (Latest Year)
Total Assets$29.15M
Current Assets$25.25M
Cash & ST Investments$6.03M
Total Liabilities$24.23M
Total Debt$4.53M
Net Debt$-1.5M
Total Equity$4.92M
Debt / Equity0.92
Valuation Ratios
P/E Ratio-4
P/S Ratio0.34
P/B Ratio3.66
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message